Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Fuchs Endothelial Corneal Dystrophy

In brief

This protocol will investigate whether topical application of N-acetyl cysteine (NAC) eye drops decreases oxidative stress and confers cytoprotection in patients with FECD.

Key facts

Study ID
NCT04440280
Run by
Massachusetts Eye and Ear Infirmary
People needed
45
Starts
2020-09-16
Expected to finish
2027-04-30
Last updated by the study team
2025-09-29

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.